Clinical Trial Update: Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of combining simeprevir with sofosbuvir in adults with chronic hepatitis C virus infection, genotype 4; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Janssen R&D Ireland | Conditions: Chronic Hepatitis C, Genotype 4 Chronic Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2016-11-17